Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspective
A
Andrew S. Robertson
N
Nahid Latif
I
Imein Bousnina
D
Donna Boyce
K
Kevin Carl
S
Sean P. Curtis
J
Jennifer Dudinak
C
Carlos O. Garner
M
Michael Garvin
S
Sabine Luik
K
Koen Nauwelaerts
E
Eddie Reilly
M
Michelle Rohrer
K
Katrin Rupalla
J
Jacintha Shenton
J
Jerry Stewart
M
Mark Taisey
A
Axel Vicart
R
Raymond C. Votzmeyer
M
Matthew P. Wagoner
M
Max Wegner
K
Kathy Williams
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 24, Issue 6
Published
June 01, 2025
Pages
401-402
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (22)
A
Andrew S. Robertson
N
Nahid Latif
I
Imein Bousnina
D
Donna Boyce
K
Kevin Carl
S
Sean P. Curtis
J
Jennifer Dudinak
C
Carlos O. Garner
M
Michael Garvin
S
Sabine Luik
K
Koen Nauwelaerts
E
Eddie Reilly
M
Michelle Rohrer
K
Katrin Rupalla
J
Jacintha Shenton
J
Jerry Stewart
M
Mark Taisey
A
Axel Vicart
R
Raymond C. Votzmeyer
M
Matthew P. Wagoner
M
Max Wegner
K
Kathy Williams
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w